Halozyme Therapeutics
HALO
#2131
Rank
โ‚ฌ8.13 B
Marketcap
68,60ย โ‚ฌ
Share price
1.58%
Change (1 day)
43.46%
Change (1 year)

Halozyme Therapeutics (HALO) - Cash on Hand

Cash on Hand as of March 2026 : โ‚ฌ0.27 Billion

According to Halozyme Therapeutics's latest financial reports the company has โ‚ฌ0.27 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Halozyme Therapeutics - Cash on Hand chart (from 2002 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31โ‚ฌ0.12 B-78.78%
2024-12-31โ‚ฌ0.57 B88.46%
2023-12-31โ‚ฌ0.30 B-10.13%
2022-12-31โ‚ฌ0.33 B-48.3%
2021-12-31โ‚ฌ0.65 B118.66%
2020-12-31โ‚ฌ0.29 B-20.44%
2019-12-31โ‚ฌ0.37 B21.34%
2018-12-31โ‚ฌ0.30 B-20.75%
2017-12-31โ‚ฌ0.39 B100.67%
2016-12-31โ‚ฌ0.19 B96.68%
2015-12-31โ‚ฌ99.08 M-11.15%
2014-12-31โ‚ฌ0.11 B115.38%
2013-12-31โ‚ฌ51.77 M-31.17%
2012-12-31โ‚ฌ75.22 M84.92%
2011-12-31โ‚ฌ40.67 M-35.01%
2010-12-31โ‚ฌ62.59 M32.92%
2009-12-31โ‚ฌ47.08 M3.32%
2008-12-31โ‚ฌ45.57 M-31.87%
2007-12-31โ‚ฌ66.89 M99.76%
2006-12-31โ‚ฌ33.48 M107.36%
2005-12-31โ‚ฌ16.15 M36.86%
2004-12-31โ‚ฌ11.8 M2850.3%
2003-12-31โ‚ฌ0.39 M329.95%
2002-12-31โ‚ฌ0.09 M214.46%
2001-12-31โ‚ฌ0.02 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ19.31 B 6,820.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ11.45 B 4,003.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ4.62 B 1,557.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ5.62 B 1,913.90%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
โ‚ฌ1.76 B 533.04%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
โ‚ฌ0.11 B-57.99%๐Ÿ‡บ๐Ÿ‡ธ USA